Medacta US Spine Division Posts 140% Growth in 2016
Medacta's U.S. Spine division posted 2016 sales growth at 140% over 2015.
The division has marked five consecutive quarters of 24% sequential growth. Within 2016, it grew its customer base at 105% and added >40 new U.S. field sales agents.
In 2016, Medacta’s Spine Division unveiled three new products, including the 3D-printed MySpine Low Profile Guide, which gained FDA 510(k) clearance in early 4Q16. Other Medacta spinal products receiving FDA clearance in the year included the M.U.S.T. Pedicle Screw and the MectaLIF Anterior Standalone anterior interbody fusion device.
Sources: Medacta International; ORTHOWORLD Inc.